Esomeprazole Magnesium
Product Images NDC 68788-8431

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 68788-8431). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole Magnesium Dr Capsules 20mg (6c70018b D2f6 409e A493 78f7e61367f4 00)

Label for Esomeprazole Magnesium DR Capsules 20mg by Preferred Pharmaceuticals Inc., generic for Nexium. The label includes dosage form, strength, manufacturer Aurobindo Pharma Limited, and storage instructions. It features warnings, barcode, and bilingual dosage directions in English and Spanish on a yellow background.*

FDA Label Image

Figure 2: Maintenance Of Healing Rates Of Ee In Adults By Month (study 177) (Esomeprazole Fig1)

A line graph showing the percent maintained over a 6-month period for Esomeprazole Magnesium in three strengths (40 mg, 20 mg, and 10 mg) and placebo. The x-axis represents months with scheduled visits marked, and the y-axis shows percent maintained. The graph compares the retention rates of different dosages and placebo over time.*

FDA Label Image

Figure 3: Maintenance Of Ee Healing Rates In Adults By Month (study 178) (Esomeprazole Fig2)

A line graph showing percent maintained over a 6-month period for Esomeprazole Magnesium at doses of 10 mg, 20 mg, and 40 mg, compared to placebo. The graph includes scheduled visits marked with 'S' and depicts a clear trend in percent maintained for each group, with higher doses maintaining higher percentages.*

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole Fig3)

A line graph showing the percent of patients symptom-free over 28 diary days. It compares Esomeprazole Magnesium delayed-release capsules at 40 mg and 20 mg doses against a placebo. The y-axis represents the percent symptom-free, ranging from 0 to 100%, and the x-axis shows diary days from 0 to 28.*

FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole Fig4)

A line graph depicting the percent of patients symptom-free over 28 diary days for Esomeprazole Magnesium delayed-release capsules at 40 mg and 20 mg doses versus placebo. The vertical axis shows percent symptom-free, and the horizontal axis shows diary days, illustrating higher symptom-free rates with both Esomeprazole Magnesium doses compared to placebo.*

FDA Label Image

Chemical Structure (Esomeprazole Str)

Chemical structure diagram of Esomeprazole Magnesium, depicting the molecular arrangement including magnesium ions and hydration with two water molecules (2H2O). The structure includes methoxy, methyl, and sulfoxide functional groups as part of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.